Effective SGLT2 Inhibitor for Patient With Type 2 Diabetes Mellitus (T2DM) and Depression

doi 10.36502/2020/droa.6160
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Asploro Open Access Publications

Related search

Ertugliflozin: A New SGLT2 Inhibitor for Type 2 Diabetes

Prescriber
Pharmacology
2019English

DPP-4/SGLT2 Inhibitor Combined Therapy for Type 2 Diabetes

Prescriber
Pharmacology
2017English

Qtern: DPP-4 and SGLT2 Inhibitor Combination for Type 2 Diabetes

Prescriber
Pharmacology
2017English

Anemia in Type 2 Diabetes Mellitus (T2dm) and Its Association With Vitamin B12 Deficiency

Indian Journal of Pathology and Oncology
2018English

P235 the Prevalence of Microalbuminuria in Children With Type 2 Diabetes Mellitus (T2DM)

2019English

Combining SGLT2 Inhibitor and GLP-1 Agonist: Exaggerated Weight Loss in a Morbidly Obese Patient With Type 2 Diabetes

British Journal of Diabetes
2016English

Safe and Effective Prescription of Metformin in Elderly Patients With Type 2 Diabetes (T2DM)

Endocrinology&Metabolism International Journal
2018English

Management of Depression in Adolescents With Type 2 Diabetes Mellitus

PLAID: People Living with And Inspired by Diabetes
2017English

SGLT2 Inhibitors: The Future for Treatment of Type 2 Diabetes Mellitus and Other Chronic Diseases

Diabetologia
Internal MedicineEndocrinologyMetabolismDiabetes
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2026 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy